Infusive Technologies Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Infusive Technologies General Information

Description

Developer of proprietary and patented multi-chamber, sequential, dose syringe technology. The company develops syringe technology developed under its product name "ChaSyr" which allows for the sequential administration of two separate intravenous (IV) medications with a single syringe, replacing multiple syringes with just one.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Acquirer
Global Holdings (Virginia)
Primary Office
  • 620 South Main Street
  • Bountiful, UT 84010
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Infusive Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Infusive Technologies‘s full profile, request access.

Request a free trial

Infusive Technologies Executive Team (2)

Name Title Board Seat Contact Info
Gale Thorne Jr. President & Chief Operating Officer
To view Infusive Technologies’s complete executive team members history, request access »